1,416 results on '"Bartsch, R"'
Search Results
2. How I treat endocrine-dependent metastatic breast cancer
3. Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group
4. Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force
5. Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18
6. Expectations and perception of cancer treatment goals in previously untreated patients. The EXPECT trial
7. 18P Association of DNA methylation profiles with pathologic complete response in early triple-negative breast cancer patients receiving neoadjuvant chemoimmunotherapy
8. Correction to: Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis
9. Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center
10. 123O Randomized phase II trial of neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in early HER2-positive breast cancer (ABCSG-52/ATHENE)
11. 260MO Long-term patient-reported outcomes in premenopausal women with the hormone receptor-positive breast cancer from ABCSG 22 Registry
12. Geruchsintensive Stoffe: Grundlagen, Bewertung und Markierung
13. Versorgungsrealität in Deutschland und Österreich – Zweite Interimsanalyse der nicht-Interventionellen Studie PERFORM für PatientInnen mit HR+/HER2- fortgeschrittenem Brustkrebs, die in der Erstlinie mit endokrin-basierter Palbociclib-Therapie behandelt werden
14. P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib
15. P009 A real-world prospective observational multi-national study in adult patients with breast cancer treated with extended adjuvant neratinib: NERLYFE study
16. Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group
17. Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
18. Present and future breast cancer management—bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry
19. Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
20. Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
21. Prognostic impact of breast cancer subtypes in elderly patients
22. OS01.5.A Neuron-specific enolase (NSE) and S100 serum levels in patients with active brain metastases from HER2-positive breast cancer treated with trastuzumab-deruxtecan (T-DXd): A biomarker analysis from the TUXEDO-1 trial
23. 307P Incidence of neurological symptoms in brain metastases from breast cancer and its impact on prognosis: An analysis of 968 patients with brain metastases
24. P23-15 Pulmonary toxicity is the most sensitive endpoint for deriving MAK values for aluminium compounds
25. LBA18 Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2+ advanced/metastatic breast cancer (mBC) with or without brain metastases (BM): DESTINYBreast-12 primary results
26. 1895P Higher modified Glasgow Prognostic Score in cancer patients at the Emergency Department is associated with an increased risk of hospital admissions
27. 356P Real-world effectiveness in subgroups of palbociclib + endocrine therapy in HR+/HER2- ABC patients: Interim results of the PERFORM study
28. Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patients
29. Herzfrequenz und EKG in der Polysomnographie
30. 165MO Trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients (pts) with active brain metastases: Primary outcome analysis from the TUXEDO-1 trial
31. 195P REACH AUT: Efficacy and safety of first-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC) from a real-world (RW) study: 3rd interim analysis
32. 75P Interim analysis (n=150) of the multi-national, prospective, non-interventional ELEANOR study observing real-life extended adjuvant treatment with neratinib in patients with HER2+ / HR+ early breast cancer (eBC)
33. 177P Low HER2 expression does not influence prognosis in metastatic triple-negative breast cancer: Results from an international, multicenter analysis coordinated by the Austrian Group Medical Tumor Therapy (AGMT)
34. Einsatz Technisches Hilfswerk (THW)
35. Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer
36. Bitumen (vapours and aerosols from high-temperature processing). MAK Value Documentation, supplement – Translation of the German version from 2019
37. Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional study
38. POSB196 Epidemiology of Osteoporosis: Risk Factor Distribution, Osteoporosis Prevalence and Treatment Gap in the General Population ≥50 Years of Age in Germany
39. Correction to: Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis
40. My personal highlights of ESMO 2016
41. Cellular Targets for SV40 Large T-Antigen
42. Amino Acid Sequences of Bacterial Cytochromes c ′ and c-556
43. On the Monoheme Character of Cytochromes c ′
44. Spin-State Correlations in near Infrared Spectroscopy of Cytochrome c ′
45. On the Monoheme Nature of Cytochrome C′ (Rhodopseudomon as Palustris)
46. 311P A global survey of the management of carcinomatous meningitis (CM) in breast cancer patients
47. 280P Intracranial activity of trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients with active brain metastases: Results from the first stage of the phase II TUXEDO-1 trial
48. 200TiP ELEANOR: A multi-national, prospective, non-interventional study (NIS) in patients with human epidermal growth factor receptor (HER2) positive, early breast cancer (eBC) observing real-life extended adjuvant treatment with neratinib and concurrent use of the eHealth solution CANKADO
49. Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study
50. Metastatic breast cancer – ASCO 2010
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.